2.4.0.8 HtmlAndXml 103 222 1 false 38 0 false 6 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.sagentpharma.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information R1.xml true false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.sagentpharma.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets R2.xml false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.sagentpharma.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) R3.xml false false R4.htm 105 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.sagentpharma.com/taxonomy/role/StatementOfIncome Condensed Consolidated Statements of Operations R4.xml false false R5.htm 106 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.sagentpharma.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income (Loss) R5.xml false false R6.htm 107 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.sagentpharma.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows R6.xml false false R7.htm 108 - Disclosure - Basis of presentation Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock Basis of presentation R7.xml false false R8.htm 109 - Disclosure - Acquisition Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock Acquisition R8.xml false false R9.htm 110 - Disclosure - Investments Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Investments R9.xml false false R10.htm 111 - Disclosure - Inventories Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventories R10.xml false false R11.htm 112 - Disclosure - Property, plant and equipment Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock Property, plant and equipment R11.xml false false R12.htm 113 - Disclosure - Goodwill and Intangible assets, net Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock Goodwill and Intangible assets, net R12.xml false false R13.htm 114 - Disclosure - Investment Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsEquityMethodInvestmentsDisclosureTextBlock Investment R13.xml false false R14.htm 115 - Disclosure - Debt Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Debt R14.xml false false R15.htm 116 - Disclosure - Accrued liabilities Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accrued liabilities R15.xml false false R16.htm 117 - Disclosure - Fair value measurements Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair value measurements R16.xml false false R17.htm 118 - Disclosure - Accumulated other comprehensive (loss) income Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock Accumulated other comprehensive (loss) income R17.xml false false R18.htm 119 - Disclosure - Earnings per share Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Earnings per share R18.xml false false R19.htm 120 - Disclosure - Stock-based compensation Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-based compensation R19.xml false false R20.htm 121 - Disclosure - Net revenue by product Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsRevenueByProductGroupsAndByGeographyTextBlock Net revenue by product R20.xml false false R21.htm 122 - Disclosure - Related party transactions Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related party transactions R21.xml false false R22.htm 123 - Disclosure - Commitments and contingencies Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and contingencies R22.xml false false R23.htm 124 - Disclosure - Basis of presentation (Policies) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlockPolicies Basis of presentation (Policies) R23.xml false false R24.htm 125 - Disclosure - Basis of presentation (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlockTables Basis of presentation (Tables) R24.xml false false R25.htm 126 - Disclosure - Acquisition (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlockTables Acquisition (Tables) R25.xml false false R26.htm 127 - Disclosure - Investments (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlockTables Investments (Tables) R26.xml false false R27.htm 128 - Disclosure - Inventories (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventories (Tables) R27.xml false false R28.htm 129 - Disclosure - Property, plant and equipment (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables Property, plant and equipment (Tables) R28.xml false false R29.htm 130 - Disclosure - Goodwill and Intangible assets, net (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables Goodwill and Intangible assets, net (Tables) R29.xml false false R30.htm 131 - Disclosure - Investment (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsEquityMethodInvestmentsDisclosureTextBlockTables Investment (Tables) R30.xml false false R31.htm 132 - Disclosure - Debt (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables Debt (Tables) R31.xml false false R32.htm 133 - Disclosure - Accrued liabilities (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accrued liabilities (Tables) R32.xml false false R33.htm 134 - Disclosure - Fair value measurements (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair value measurements (Tables) R33.xml false false R34.htm 135 - Disclosure - Accumulated other comprehensive (loss) income (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlockTables Accumulated other comprehensive (loss) income (Tables) R34.xml false false R35.htm 136 - Disclosure - Earnings per share (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Earnings per share (Tables) R35.xml false false R36.htm 137 - Disclosure - Net revenue by product (Tables) Sheet http://www.sagentpharma.com/taxonomy/role/NotesToFinancialStatementsRevenueByProductGroupsAndByGeographyTextBlockTables Net revenue by product (Tables) R36.xml false false R37.htm 138 - Disclosure - Basis of Presentation - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation Basis of Presentation - Additional Information (Detail) R37.xml false false R38.htm 139 - Disclosure - Estimated Useful Life of Property Plant and Equipment (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureEstimatedUsefulLifeOfPropertyPlantAndEquipment Estimated Useful Life of Property Plant and Equipment (Detail) R38.xml false false R39.htm 140 - Disclosure - Acquisition - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureAcquisitionAdditionalInformation Acquisition - Additional Information (Detail) R39.xml false false R40.htm 141 - Disclosure - Future Payments Related to Acquisition (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureFuturePaymentsRelatedToAcquisition Future Payments Related to Acquisition (Detail) R40.xml false false R41.htm 142 - Disclosure - Purchase Consideration related to Acquisition (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosurePurchaseConsiderationRelatedToAcquisition Purchase Consideration related to Acquisition (Detail) R41.xml false false R42.htm 143 - Disclosure - Allocation of Purchase Price (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureAllocationOfPurchasePrice Allocation of Purchase Price (Detail) R42.xml false false R43.htm 144 - Disclosure - Pro Forma Operations Results (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureProFormaOperationsResults Pro Forma Operations Results (Detail) R43.xml false false R44.htm 145 - Disclosure - Investments (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureInvestments Investments (Detail) R44.xml false false R45.htm 146 - Disclosure - Investments with Continuous Unrealized Losses for Less Than Twelve Months and Related Fair Values (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureInvestmentsWithContinuousUnrealizedLossesForLessThanTwelveMonthsAndRelatedFairValues Investments with Continuous Unrealized Losses for Less Than Twelve Months and Related Fair Values (Detail) R45.xml false false R46.htm 147 - Disclosure - Cost and Estimated Current Fair Value of Fixed-Income Securities (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureCostAndEstimatedCurrentFairValueOfFixedIncomeSecurities Cost and Estimated Current Fair Value of Fixed-Income Securities (Detail) R46.xml false false R47.htm 148 - Disclosure - Inventories (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureInventories Inventories (Detail) R47.xml false false R48.htm 149 - Disclosure - Inventories - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureInventoriesAdditionalInformation Inventories - Additional Information (Detail) R48.xml false false R49.htm 150 - Disclosure - Property Plant and Equipment (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosurePropertyPlantAndEquipment Property Plant and Equipment (Detail) R49.xml false false R50.htm 151 - Disclosure - Property Plant and Equipment - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformation Property Plant and Equipment - Additional Information (Detail) R50.xml false false R51.htm 152 - Disclosure - Goodwill and Intangible assets, net - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetAdditionalInformation Goodwill and Intangible assets, net - Additional Information (Detail) R51.xml false false R52.htm 153 - Disclosure - Schedule of Intangible Assets (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureScheduleOfIntangibleAssets Schedule of Intangible Assets (Detail) R52.xml false false R53.htm 154 - Disclosure - Movements in Intangible Assets (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureMovementsInIntangibleAssets Movements in Intangible Assets (Detail) R53.xml false false R54.htm 155 - Disclosure - Schedule of Estimate Amortization Expense over Each of the Next Five Years (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureScheduleOfEstimateAmortizationExpenseOverEachOfTheNextFiveYears Schedule of Estimate Amortization Expense over Each of the Next Five Years (Detail) R54.xml false false R55.htm 156 - Disclosure - Changes in Investment of Sagent Agila (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureChangesInInvestmentOfSagentAgila Changes in Investment of Sagent Agila (Detail) R55.xml false false R56.htm 157 - Disclosure - Condensed Statement of Operations Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureCondensedStatementOfOperationsInformation Condensed Statement of Operations Information (Detail) R56.xml false false R57.htm 158 - Disclosure - Changes in Investment of Kanghong Sagent Pharmaceutical Corporation Limited (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureChangesInInvestmentOfKanghongSagentPharmaceuticalCorporationLimited Changes in Investment of Kanghong Sagent Pharmaceutical Corporation Limited (Detail) R57.xml false false R58.htm 159 - Disclosure - Investment in KSCP - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureInvestmentInKSCPAdditionalInformation Investment in KSCP - Additional Information (Detail) R58.xml false false R59.htm 160 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) R59.xml false false R60.htm 161 - Disclosure - Principal Payments Due on Credit Facility (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosurePrincipalPaymentsDueOnCreditFacility Principal Payments Due on Credit Facility (Detail) R60.xml false false R61.htm 162 - Disclosure - Accrued Liabilities (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureAccruedLiabilities Accrued Liabilities (Detail) R61.xml false false R62.htm 163 - Disclosure - Summary of Assets Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureSummaryOfAssetsMeasuredAtFairValueOnRecurringBasis Summary of Assets Measured at Fair Value on Recurring Basis (Detail) R62.xml false false R63.htm 164 - Disclosure - Accumulated Other Comprehensive Loss Income (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureAccumulatedOtherComprehensiveLossIncome Accumulated Other Comprehensive Loss Income (Detail) R63.xml false false R64.htm 165 - Disclosure - Component of Accumulated Other Comprehensive Income (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureComponentOfAccumulatedOtherComprehensiveIncome Component of Accumulated Other Comprehensive Income (Detail) R64.xml false false R65.htm 166 - Disclosure - Amounts Reclassified Out of Accumulated Other Comprehensive Loss (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureAmountsReclassifiedOutOfAccumulatedOtherComprehensiveLoss Amounts Reclassified Out of Accumulated Other Comprehensive Loss (Detail) R65.xml false false R66.htm 167 - Disclosure - Earnings Per Share - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureEarningsPerShareAdditionalInformation Earnings Per Share - Additional Information (Detail) R66.xml false false R67.htm 168 - Disclosure - Schedule of Calculation of Numerator and Denominator in Earnings Per Share (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureScheduleOfCalculationOfNumeratorAndDenominatorInEarningsPerShare Schedule of Calculation of Numerator and Denominator in Earnings Per Share (Detail) R67.xml false false R68.htm 169 - Disclosure - Stock- Based Compensation - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation Stock- Based Compensation - Additional Information (Detail) R68.xml false false R69.htm 170 - Disclosure - Schedule of Net Amount of Risk by Product and Guarantee (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureScheduleOfNetAmountOfRiskByProductAndGuarantee Schedule of Net Amount of Risk by Product and Guarantee (Detail) R69.xml false false R70.htm 171 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.sagentpharma.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation Related Party Transactions - Additional Information (Detail) R70.xml false false All Reports Book All Reports Process Flow-Through: 103 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 105 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: 106 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Process Flow-Through: 107 - Statement - Condensed Consolidated Statements of Cash Flows sgnt-20130630.xml sgnt-20130630.xsd sgnt-20130630_cal.xml sgnt-20130630_def.xml sgnt-20130630_lab.xml sgnt-20130630_pre.xml true true